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Several thousand genes in the human genome have been linked to a heritable genetic disease. The majority of these
appear to be nonessential genes (i.e., are not embryonically lethal when inactivated), and one could therefore speculate
that they are late additions in the evolutionary lineage toward humans. Contrary to this expectation, we ﬁnd that they are
in fact signiﬁcantly overrepresented among the genes that have emerged during the early evolution of the metazoa. Using
a phylostratigraphic approach, we have studied the evolutionary emergence of such genes at 19 phylogenetic levels. The
majority of disease genes was already present in the eukaryotic ancestor, and the second largest number has arisen around
the time of evolution of multicellularity. Conversely, genes speciﬁc to the mammalian lineage are highly
underrepresented. Hence, genes involved in genetic diseases are not simply a random subset of all genes in the
genome but are biased toward ancient genes.
Introduction
Most genes involved in basic cellular processes have
already evolved in the unicellular ancestor of eukaryotes.
Other large groups of genes, most notably those involved
in signaling processes, can be traced back to multicellular
metazoan evolution (King et al. 2008). At the other end of
the spectrum are the orphan genes, which are restricted to
particulartaxonomicgroups.Althoughitseemsevidentthat
such genes should be associated with lineage-speciﬁc adap-
tations, they are still not much studied and a general role
could not yet be ascribed to them. We have previously
shown that many orphan genes show high substitution
rates, although some of them may also evolve very slowly,
suggesting major lineage-speciﬁc functions (Domazet-Lo-
s ˇo and Tautz 2003).
To quantify and statistically analyze gene emergence
at different levels of the taxonomic hierarchy, we have de-
velopedaphylostratigraphicapproach(Domazet-Los ˇoetal.
2007). In this method, one uses a set of more or less com-
pletely sequenced genomes to represent the full tree of eu-
karyotic life, accentuated by key innovations reﬂected at
phylogenetic levels, called phylostrata. This framework
is used to place the genes of a given genome into those phy-
lostrata where homologues can be found by Blast analysis.
We have used this approach here to study the evolutionary
origin of genes that were implicated in causing human ge-
netic diseases.
The Online Mendelian Inheritance in Man, OMIM
(TM) (2008) database lists currently more than 4,000 chro-
mosome regions that have been associated with a genetic
disease and for about half of them, the disease-causing mu-
tation has been identiﬁed. Hence, a signiﬁcant part of the
human genome is susceptible to mutations that cause dis-
eases. These genes have been further classiﬁed into essen-
tial and nonessential genes based on the comparison with
data from the mouse (Goh et al. 2007; Feldman et al. 2008).
A knockout of an essential gene leads to embryonic lethal-
ity, whereas nonessential genes can show a range of phe-
notypes when inactivated. Although there is an ongoing
discussion on how predictive the comparisons with the
mouse are for the function of the genes in humans (Liao
and Zhang 2008), it is nonetheless clear that this general
categorization can be applied to the majority of genes.
Based on the analysis of Goh et al. (2007) and Liao and
Zhang (2008), one can estimate that between 60% and
75% of disease genes are nonessential genes.
It was shown that nonessential disease genes are less
likely to represent hubs in gene interaction networks, that
they have fewer interacting partners, and that their expres-
sion patterns are lesslikelytobecorrelatedwithother genes
(Goh et al. 2007; Feldman et al. 2008). Furthermore, it has
been shown that genes at the periphery of network hubs are
more often subject to positive selection (Kim et al. 2007),
suggesting that they are particularly important for creating
evolutionary novelties. In evolutionary terms, one could
therefore place them in the category of late additions in
the lineage toward humans. On the other hand, already
the ﬁrst genome comparisons showed that many disease
genes can be found in species distantly related to humans
(Rubin et al. 2000). Thus, one can ask whether disease
genes are simply a random subset of all genes or whether
they fall into a particular evolutionary age class that might
be correlated to evolutionary innovations in the human
lineage.
Methods
Phylostratigraphic Analysis
Phylostratigraphic analysis was done according to the
procedure described in Domazet-Los ˇo et al. (2007). Human
protein sequences were retrieved from Ensembl (version
45), and only the longest splicing variants were kept
(22,937 unique proteins). The BlastP algorithm (0.001 E
value cutoff) was used to compare human proteins against
the National Center for Biotechnology Information (NCBI)
non-redundant (NR) database. Before the sequence similar-
ity search was done, the NR database was cleaned up with
respect tosequences of uncertain taxonomic status or where
the taxonomy ID is not included in the cellular organisms
section of the NCBI taxonomy database. Additionally, we
removed from the database sequences of metazoan taxa
with unreliable phylogenetic position (Mesozoa, Myxozoa,
Chaetognatha, and Placozoa). After this clean up
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nomes that were absent in the database but otherwise were
publicly available (ﬁg. 1). Additionally, TBlastN search
(10
15 E value cutoff) was done against substantial trace
and EST archives of Porifera, Cyclostomata, and Chon-
drichtyes (phylostrata 6 and 11) as for these internodes
complete annotated genomes were lacking. The higher
threshold for the trace and EST archives was necessary be-
cause of the different data structure. Using the Blast output
and MS SQL database management system in a series of
queries, we mapped human genes according to the evolu-
tionary origin of their founder genes on the currently best
supported phylogeny (ﬁg. 1). Note that in a recent study,
ctenophores where recovered as the earliest diverging mul-
ticellular animals (Dunn et al. 2008). However, shifting of
their position among major metazoan groups does not in-
ﬂuence our results as their genome sequence is not yet
available and as almost all individual ctenophore genes
which are included in the NCBI database are highly con-
served and are mapping before the metazoans. Taken
together, our choice of internodes is based on the availabil-
ity of complete annotated genomes, the reliability of phy-
logenetic relationships, and the importance of evolutionary
transitions. The accession numbers of all genes sorted into
the phylostrata are provided in supplementary table S3
(Supplementary Material online).
Statistical Analysis of Phylostratigraphic Data
The frequency of the disease genes in every phylostra-
tum was compared with the frequency of disease genes in
the complete genome (expected frequency), and deviations
are shown by calculating log-odds ratios (ﬁg. 2). Signiﬁ-
cance of the obtained deviations from the expected fre-
quency was tested by two-tailed hypergeometric tests
(Rivals et al. 2007), and obtained P values were corrected
for multiple comparisons via false discovery rate (FDR) at
0.05 level (Benjamini and Hochberg 1995). Similarly, we
testedforsigniﬁcantfrequencydeviationsofeachGeneOn-
tology (GO) term in every phylostratum compared with the
complete population of GO annotations for the whole gene
set (supplementary table S1, Supplementary Material on-
line) and the disease gene set (supplementary table S2, Sup-
plementary Material online). As before, signiﬁcance of the
obtained frequency deviations was tested by two-tailed hy-
pergeometric tests and correction for multiple comparison
was done by FDR at the 0.05 level.
Precalculated protein evolutionary rates for Ensemble
human–mouse orthologs were retrieved from http://
www.biomart.org/. Signiﬁcance of the difference in evo-
lutionary rates between the human disease (N 5 1,641)
and the reference (N 5 14,462) set of genes was tested
by Student’s t.
Nonessential and Polygenic Disease Genes
The total number of recovered disease genes was 1,760
basedonMorbidmap(OMIM,Tag3).Thissetofdiseasegenes
(Tag 3) includes only cases where the mutation was both po-
sitioned by mapping the wild-type gene and the disease phe-
notype itself, combined with the demonstration that
a mutation in that gene is associated with the disorder (see
http://www.ncbi.nlm.nih.gov/Omim/omimfaq.html). We ob-
tainedthesubsampleofnonessentialdiseasegenesintwoways,
onemorestringentandtheothermorepermissive.Thestringent
subsample(1,020genes)wasobtainedbyremovinggenesthat
essentially reduce the ﬁtnesstozero. Thesegeneswere anno-
tated in the mouse knockout database (http://www.informa-
tics.jax.org/) as ‘‘lethality-prenatal/perinatal’’(MP:0005374),
‘‘lethality postnatal’’ (MP:0005373),or ‘‘reproductive system
phenotype’’ (MP:0005389) and by removing genes that
were annotated as essential based on human phenotype data
FIG. 1.—Phylogenetic framework used in the search for the human gene origins. Taxa represented in the databases with complete genomes or
a substantial amount of TRACE and EST data are in bold. Taxa in italics are represented in the databases only with small numbers of highly conserved
genes, and their exclusion from the analysis does not inﬂuence the results.
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sential genes (1,305) was obtained by removing genes that
were annotated in the mouse knockout database as lethal-
ity-prenatal/perinatal(MP:0005374). The list of 149 genes
implicatedinthehumanpolygenictraitswerecompiledfrom
several studies (Diabetes Genetics Initiative of Broad Insti-
tute of Harvard and MIT, LundUniversity, and Novartis In-
stitutes of BioMedical Research et al. 2007; Zeggini et al.
2007; Wellcome Trust Case Control Consortium 2007a;
Wellcome Trust Case Control Consortium and Australo-
Anglo-American Spondylitis Consortium (TASC) 2007b;
Lettre et al. 2008; Weedon et al. 2008).
FIG. 2.—Phylostratigraphy of all human genes and different classes of disease-causing genes. The total number of human genes (N 5 22,845)
found in the different phylostrata is plotted (blue line—squares, note logarithmic scale on the y axis). Distribution of the total number of evaluated
disease genes (N 5 1,760, red line—circles). The subsample of nonessential disease genes (N 5 1,305), the stringent nonessential subsample
(N 5 1,020), and the genes involved in polygenic traits (N 5 149) are also shown. The correlation coefﬁcient between gene count and ranked
evolutionary time is listed on top (estimated by Spearman’s rank correlation coefﬁcient).
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Basedonthecurrentlyavailablegenomedata,wehave
created a phylostratigraphic scheme of metazoan evolution
thatincludes19phylostrata(ﬁg.1).Thetaxonomicarrange-
ment is based on a consensus phylogeny that is supported
by a range of molecular and morphological data (Bourlat
etal.2006;Nikolaevetal.2007;Dunnetal.2008).Toplace
all human genes into these phylostrata, we use Blast anal-
ysis with an E value cutoff of 0.001. This can be considered
to be rather nonstringent, but we have previously found that
this cutoff provides an optimal speciﬁcity with respect to
the detection of orphan genes (Domazet-Los ˇo and Tautz
2003). It should be noted that this permissive cutoff will
placeallgenefamiliesthatshareaparticularproteindomain
into the age class where this domain emerged ﬁrst, even
though a particular gene may have evolved later, for exam-
ple, due to gene duplication or exon shufﬂing. On the other
hand,because aproteindomainisusuallylinkedtoacertain
function, we trace the origin of this function in our analysis,
irrespective of the further origin of paralogues.
Figure 2shows the originof 22,845 human genes plot-
ted onto the 19 phylostrata (ps). Approximately 60% of
them trace back to the origin of life and the emergence
of eukaryotic cells (ps1 and ps2). These genes usually rep-
resent basic cellular functions, such as metabolic processes
and transcriptional regulation (supplementary table S1,
Supplementary Material online). Another peak of gene
emergence is associated with the evolution of multicellular-
ity, shortly before the Cambrian explosion (ps6). Signaling
processes such as G-protein–based signaling date back to
this time. Smaller peaks are evident around the emergence
of bony ﬁsh/tetrapoda (ps11 and ps12) and eutherian mam-
mals (ps16). These peaks are mainly associated with the
emergence of immunity-related genes. Finally, there is
an additional peak around the emergence of primates
(ps19), where genes involved in spermatogenesis and kera-
tinization are enriched. About 13% of all genes in humans
have emerged in the mammalian lineage (ps15 and later)
and can therefore be considered to be orphans for this tax-
onomic group.
To assess the distribution of disease-associated genes
across the phylostrata, we have focused on the subset of
genes for which a disease-causing mutation was identiﬁed
(see Methods). Plotting these genes onto the same topology
as for the full gene set shows a different pattern. Although
the peaks of disease gene emergence mimic those of the
emergence of all genes for the older phylostrata, they be-
come notably absent from the younger phylostrata (ﬁg.
2). Only about 0.6% of the disease genes map to ps16 or
later. The genes in this class tend to be accessory proteins,
such as APOC2 (apolipoprotein C-II, a component of very
low density lipoprotein), MRAP (melanocortin 2 receptor
accessory protein), or MUC7 (a salivary mucin thought to
functioninaprotectivecapacitybypromotingtheclearance
of bacteria in the oral cavity).
The pattern is not very different when one plots non-
essential genes only. The same peaks of emergence are
seen, irrespective of whether one uses a stringent or non-
stringent subset (see Methods) of nonessential genes (ﬁg.
2). In statistical terms, the comparison of the number of dis-
ease genes against the ranked evolutionary time, repre-
sented by the phylostrata, shows a signiﬁcant negative
correlation (Spearman’s rho, ﬁg. 2), indicating that contin-
uously fewer disease-related genes originated over evolu-
tionary time. Such a statistically signiﬁcant correlation is
not seen for the whole gene set (ﬁg. 2).
To assess whether the functions of disease genes are
a more or less random subset of the functions of the whole
gene set at the different phylostrata, we compared the over-
represented GO term annotations for both groups (supple-
mentary table S2, Supplementary Material online). Table 1
lists all overrepresented GO terms for the disease genes and
compares the relative rank of the same term in the whole
gene set. It is evident that there is a remarkable overlap.
The most frequent terms are often the same in both lists.
With few exceptions, an overrepresented term in one list
is also overrepresented in the other list. The notable excep-
tion concerns the terms associated with multicellular de-
velopmental patterns in ps1 and ps2, which are not
overrepresented in the full gene list. These are evidently
genes that are only indirectly related to multicellularity be-
cause ps1 and ps2 cover phylostrata where only single-
celled organisms existed (note that a given gene can have
multipleGOterms,i.e.,itsfunctionisnotfullydescribedby
a single term). Further discrepancies are observed in ps15
and ps17, but these concern only very small numbers of
genes.
The disease genes considered up to this point are
mostly related to monogenic diseases because the system-
atic mapping of genes involved in common polygenic dis-
eases has only recently become possible (Wellcome Trust
Case Control Consortium 2007). We have compiled a list
of 149 genes that have emerged from these studies so far,
although many more are expected to come. Because each
of these genes contributes only a small fraction to the full
phenotype, one could consider them as modiﬁer genes in
a complex pathway, that is, orphan genes could easily be
among them. However, we ﬁnd again that their distribu-
tion in the phylostratigraphy mimics that of the other
genes (ﬁg. 2).
Phylostratigraphy does not only allow to plot gene
emergence to particular phylostrata but allows also a statis-
tical analysis in terms of relative over- or underrepresenta-
tion of particular gene classes in each phylostratum. This is
achieved by calculating a hypergeometric statistics, the re-
sults of which are shown as odds ratios in ﬁgure 3. The re-
sults conﬁrm that disease genes are statistically highly
signiﬁcantly underrepresented from ps15 onward, that is,
since the evolution of mammals. Also, a highly signiﬁcant
statistical overrepresentation is seen for ps1 and ps5 for the
whole disease gene set. Interestingly, overrepresentation in
ps5 predates the peak in ps6 that is seen in the overall data-
set. On the other hand, disease genes are highly signiﬁ-
cantly underrepresented among the genes that have
emerged in ps2. This is somewhat surprising because this
phylostratum represents the origin of eukaryotes, that is,
one of the major evolutionary transitions where many novel
cellular structures and processes were generated (de Duve
2007). It is also the phylostratum with the second largest
absolute number of gene emergence (ﬁg. 2), but disease-
causing genes are evidently less likely to be among them.
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Comparison of Overrepresented GO Terms among the Disease Gene Set with the Rank Order of
the Same Term among the Overrepresented GO Terms in the Whole Gene Set
PS GO Term Overrepresented among Disease Genes
Rank among
All Genes
1 Metabolic process 1
Electron transport 4
Protein amino acid phosphorylation 3
Carbohydrate metabolic process 5
Phosphate transport 28
Proteolysis 3
Ion transport 8
Transport 15
Homophilic cell adhesion 7
Epidermis development n.s.
2 Regulation of transcription, DNA dependent 1
Multicellular organismal development n.s.
Protein amino acid dephosphorylation 30
Ubiquitin cycle 3
Regulation of Rho protein signal transduction 7
Transcription 2
Dephosphorylation 49
Organ morphogenesis n.s.
Forebrain development n.s.
3
Regulation of transcription, DNA dependent 1
Transcription 2
4 Transcription 3
Regulation of transcription, DNA dependent 2
Positive regulation of transcription from RNA polymerase II promoter 4
Multicellular organismal development 5
Wnt receptor signaling pathway, calcium modulating pathway 1
5 G-protein–coupled receptor protein signaling pathway 1
Signal transduction 3
Activation of adenylate cyclase activity 15
Protein–chromophore linkage 16
Regulation of transcription 9
Brown fat cell differentiation 41
G-protein signaling, coupled to cyclic nucleotide second messenger 5
G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) 7
Sensory perception of taste n.s.
Diet-induced thermogenesis 34
G-protein signaling, coupled to cAMP nucleotide second messenger 14
Heat generation 37
Heat generation 37
Vasodilation by norepinephrine–epinephrine involved in regulation of systemic arterial
blood pressure
35
Phototransduction 20
6 Cell communication 1
Cell–cell signaling 3
7 Methylation 1
8 Calcium-independent cell–cell adhesion 1
9 Immune response 2
Antigen processing and presentation 1
Antigen processing and presentation of peptide antigen via MHC class I 4
Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II 3
Peripheral nervous system development 23
10 Cell surface receptor–linked signal transduction 4
Response to virus 1
Immune response 2
Feeding behavior 12
Cell–cell signaling 3
Cellular calcium ion homeostasis 8
Neutrophil apoptosis 16
Inﬂammatory response 5
JAK–STAT cascade 20
11 None
12 Immune response 1
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Our data show that disease-associated genes are not
simply a random subset of all genes in the human genome.
There is a clear bias toward old genes among them, and the
more recently evolved genes are seldomly disease associ-
ated. On the other hand, disease-associated genes appear to
be a typical subset of all types of older genes, that is, their
overall functional spectrum is not different from the whole
set, as judged from the GO term analysis. This makes it
even more surprising that newly evolved genes are rarely
found among them.
It has been suggested that the ability to detect the or-
igin of genes via Blast analysis could depend on their evo-
lutionary rate (Elhaik et al. 2005). This effect could
potentially affect our analysis, but our error would be on
the conservative side. Genes with higher rates would be
placed at younger phylostratigraphic levels than their true
origin, that is, a fraction of the genes studied here could
even be older than currently classiﬁed. On the other hand,
the simulation study of Elhaik et al. (2005) assumed homo-
geneous substitution rates along the protein sequence,
which is an unrealistic scenario. Alba and Castresana
(2007)havearguedthatproteinsusuallyshowanamong-site
heterogeneity in substitution rates, owing to the presence of
functional modules. Simulating such conditions, they show
that the origin of a given gene can be accurately traced by
Blast (Alba and Castresana 2007). Given that our nonstrin-
gentcutoffEvalueof0.001islikelytocatchsuchfunctional
modules, we conclude that our phylostratigraphic analysis
does indeed trace the true origin of most genes.
Our Blast search estimates the greatest age of all genes
that share a conserved domain with the focal gene, that is,
a speciﬁc disease gene could have arisen later through gene
duplication, whereas its paralogue might not be involved in
genetic diseases. However, given the large evolutionary
timesthat wespan in our analysis,it isdifﬁcultto say which
history of duplications has lead to a particular gene, that is,
to distinguish the original gene from its paralogues. We
have previously argued that extant genes may retain the
functional properties of their founders (see detailed theoret-
ical explanation in the main text and in the supplement of
Domazet-Los ˇo et al. 2007). Thus, our method estimates the
propensity of descendants of a particular founder to be in-
volved in diseases. Also, we use the same analysis stand-
ards for the disease gene set and the reference set and
believe therefore that our results would not be very differ-
ent, if one could indeed trace the evolutionary history for
each gene analyzed.
Another possible source of error could be an ascertain-
ment bias in gene discovery. There might be a bias in disease
gene discovery toward candidate genes that are conserved
amongspecies.However,becausethemajorityofmonogenic
disease genes were discovered by map-based approaches
with subsequent conﬁrmation of the disease-causing muta-
tion, this bias should not be strong. Also, it could not explain
the relative absence of disease genes from phylostratum 2 or
theoverabundanceinps5.Thesituationmightbedifferentfor
the genes involved in polygenic phenotypes. The current
studies are focused on genes with relatively strong or at least
moderate phenotypic effects because the recovery of weak
effect genes will require to study even larger cohorts of pa-
tients (Visscher 2008). It remains therefore open whether the
pattern of gene emergence seen for the genes involved in
polygenic phenotypes will change over time.
A previous analysis of evolutionary parameters in dis-
ease gene sets has suggested that they evolve faster than the
nondisease gene set (Smith and Eyre-Walker 2003). When
we compare mean dn and dn/ds calculated on the human–
mouse orthologs in our data set (16,103 pairs, 1,641 disease
genes), we were unable to see signiﬁcant differences (dn,
disease genes 50.104, nondisease genes 50.108; P 5 0.4
Student’s t; dn/ds, disease genes 5 0.158, nondisease
genes 5 0.169; P 5 0.6 Student’s t). Kondrashov et al.
(2004) found lower divergence rates for the disease genes
than for the reference set, which is also different from our
Table 1
Continued
PS GO Term Overrepresented among Disease Genes
Rank among
All Genes
13 Lipoprotein metabolic process 1
Lipid transport 4
Negative regulation of lipid catabolic process n.s.
Neutrophil activation n.s.
Regulation of cytokine production n.s.
Negative regulation of lipoprotein metabolic process n.s.
Cell surface receptor–linked signal transduction n.s.
Regulation of cholesterol absorption n.s.
Positive regulation of interleukin-8 biosynthetic process n.s.
14 None
15 Keratinization 4
Peptide cross-linking n.s.
Keratinocyte differentiation n.s.
Protein homooligomerization n.s.
16 None
17 None
NOTE.—‘‘n.s.’’ means that the term was not signiﬁcantly overrepresented in the whole gene set.
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directly comparable. The issue of faster or slower evolution
of disease genes must therefore be considered as open at
present. On the other hand, our data agree with the two
other studies (Smith and Eyre-Walker 2003; Kondrashov
et al. 2004) with respect to the ﬁnding that disease genes
tend to be old and are on average longer than the genes
in the reference set (for our data set: average length of dis-
ease genes 5 747 amino acids, nondisease genes 5 478
amino acids). To exclude the possibility that this could bias
the efﬁciency of the Blast analysis, we restricted our search
to disease genes shorter than 500 amino acids. This yielded
qualitatively the same results as with the full set (supple-
mentary ﬁg. S1, Supplementary Material online). Interest-
ingly, if one plots the average length of genes for all
phylostrata, one gets an almost continuous decrease of
lengthfromoldphylostratatoyoungerones(supplementary
ﬁg. S2, Supplementary Material online). Thus, the length
effect seen in the disease genes is a correlated effect of them
being generally older than the reference set.
Our ﬁndings have some general evolutionary implica-
tions. Although interaction network and transcriptional
analyses suggest that disease genes are not concentrated
in hubs (Goh et al. 2007; Feldman et al. 2008), their ancient
origin suggests that they are nonetheless involved in old
biological processes. In fact, it has been shown that dis-
ease-causing mutations tend to occur at conserved positions
in the proteins (Miller and Kumar 2001; Mooney and Klein
2002). Although there is—to our knowledge—currently
no general theory on the emergence of genetic diseases,
one would nonetheless not have suspected that biological
processes that have emerged early in evolution should
be most vulnerable to them. Disease-causing mutations
should affect ﬁtness and should therefore be lost over
time. Thus, over extended evolutionary times, one could
expect that genes that are subject to such mutations could
become optimized to reduce these detrimental effects.
However, because this is apparently not the case, one
canconcludethatgeneticdiseasesareaninescapablecom-
ponent of life.
Another aspect of our ﬁnding is that there is still no
new clue toward a general function of lineage-speciﬁc or-
phan genes. Such genes are found in practically all ge-
nome comparisons, both in eukaryotes and prokaryotes
FIG. 3.—Probabilities of over- or underrepresentation of disease-causing genes in the respective phylostrata. Log-odds ratios show how the
frequency of disease genes in each phylostratum deviates from the expected one estimated from the whole set of genes. Numbering of the phylostrata
corresponds to those in ﬁgures 1 and 2 (*P , 0.05; **P , 0.01; ***P , 0.001, two-tailed hypergeometric test corrected for multiple comparison by
FDR at 0.05 level).
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2004). Hence, they must be expected to play a role in
the respective lineages and that they are likely to contrib-
ute to lineage-speciﬁc adaptations. But the fact that they
are underrepresented in genetic screens (Domazet-Los ˇo
and Tautz 2003) and among disease genes, as shown here,
remains unexplained.
A more practical implication of our ﬁnding concerns
biomedical research strategies. Given that over 90% of the
disease genes have emerged before the bilaterian radia-
tion, it seems highly justiﬁed to use organisms that are
evolutionarily very remote from humans, such as nemat-
odes or insects, as models for studying the function of dis-
ease genes. Conversely, the prevalent use of mouse as
a model system would not seem as pressing as it currently
is because there are less than 2% of disease genes which
would not also be present in zebraﬁsh, for example (al-
though the functional roles of some of these genes may
change over time—Liao and Zhang 2008). Furthermore,
to understand the context of the biological processes in
which a gene is involved, it may be advisable to use model
organisms that represent the evolutionary level at which
these genes emerged.
Supplementary Material
Supplementary tables S1–S3and ﬁgures S1and S2are
available atMolecular BiologyandEvolutiononline(http://
www.mbe.oxfordjournals.org/).
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